Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion type Assertion NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_head.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion description "[We have also reported that the restoration of CL2/CCDC80 expression reverted the malignant phenotype of thyroid carcinoma cell lines and that CL2/CCDC80 positively regulated E-cadherin expression, an ability that likely accounts for the role of the CL2/CCDC80 gene in thyroid cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_provenance.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion evidence source_evidence_literature NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_provenance.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion SIO_000772 25497869 NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_provenance.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion wasDerivedFrom befree-2016 NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_provenance.
- NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_assertion wasGeneratedBy ECO_0000203 NP1247048.RAvQQF_PG6kw0zfCdvMzun8V0HDaoeiGFjF7BmqbFzhGk130_provenance.